Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 08:18 am Sale | 2021-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS | RTW Investments, LP | 2,013,601 9.700% | -450,000 (-18.27%) | Filing History |
| 2022-02-11 5:21 pm Sale | 2021-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS | Vivo Capital IX, LLC | 2,987,331 14.400% | -257,704 (-7.94%) | Filing History |
| 2022-01-28 2:09 pm Sale | 2021-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS | Frazier Life Sciences IX, L.P. | 1,417,157 6.900% | -500,000 (-26.08%) | Filing History |
| 2021-02-16 4:37 pm Purchase | 2020-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS | FLYING L INVESTMENTS XI LLC | 1,206,051 5.880% | 1,206,051 (New Position) | Filing History |
| 2021-02-16 3:46 pm Purchase | 2020-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS | Perceptive Advisors LLC | 1,296,416 6.400% | 1,296,416 (New Position) | Filing History |
| 2021-02-16 3:34 pm Sale | 2020-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS | Cormorant Asset Management, LP | 1,714,269 8.450% | -249,999 (-12.73%) | Filing History |
| 2021-02-12 5:21 pm Purchase | 2020-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS | Azamian Bobak R. | 1,915,295 9.040% | 1,915,295 (New Position) | Filing History |
| 2021-02-12 5:19 pm Purchase | 2020-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS | Ackermann Michael | 1,467,020 7.070% | 1,467,020 (New Position) | Filing History |
| 2021-02-12 09:42 am Unchanged | 2020-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS | RTW Investments, LP | 2,463,601 12.130% | 0 (Unchanged) | Filing History |
| 2020-10-30 5:00 pm Purchase | 2020-10-20 | 13D | Tarsus Pharmaceuticals, Inc. TARS | Horowitz Limited Partnership VIII | 1,987,105 10.300% | 1,987,105 (New Position) | Filing History |
| 2020-10-30 4:00 pm Purchase | 2020-10-20 | 13G | Tarsus Pharmaceuticals, Inc. TARS | Cormorant Asset Management, LP | 1,964,268 9.780% | 1,964,268 (New Position) | Filing History |
| 2020-10-28 4:31 pm Purchase | 2020-10-20 | 13G | Tarsus Pharmaceuticals, Inc. TARS | Vivo Capital IX, LLC | 3,245,035 16.200% | 3,245,035 (New Position) | Filing History |
| 2020-10-26 2:16 pm Purchase | 2020-10-16 | 13G | Tarsus Pharmaceuticals, Inc. TARS | RTW Investments, LP | 2,463,601 12.790% | 2,463,601 (New Position) | Filing History |
| 2020-10-23 1:40 pm Purchase | 2020-10-20 | 13G | Tarsus Pharmaceuticals, Inc. TARS | Frazier Life Sciences IX, L.P. | 1,917,157 9.500% | 1,917,157 (New Position) | Filing History |